| Control group | nab-P group | AP group | |
---|---|---|---|---|
WB (relative gray value) | Bax | 0.04 ± 0.01 | 0.13 ± 0.07 | 0.14 ± 0.09 |
bcl-2 | 0.26 ± 0.01 | 0.09 ± 0.01 | 0.09 ± 0.01 | |
p-VEGFR-2 | 0.14 ± 0.04 | 0.14 ± 0.06 | 0.04 ± 0.01 | |
MMP-2 | 0.14 ± 0.01 | 0.04 ± 0.01 | 0.05 ± 0.01 | |
IF (positive rate%) | Bax | 2.01% ± 0.39 | 13.87% ± 1.91** | 14.17% ± 1.69** |
bcl-2 | 23.9% ± 1.04 | 13.87% ± 2.45** | 15.67% ± 1.31** | |
p-VEGFR-2 | 25.17% ± 0.97 | 25.8% ± 1.94 | 7.4% ± 0.88** | |
MMP-2 | 19.3% ± 1.16 | 10.4% ± 0.85** | 10.83% ± 1.92** | |
Transwell (invasion cellular amount) | 389 ± 25.8 | 41 ± 7.6** | 53 ± 4.7** | |
Wound healing (Area recovery%) | 12 h | 63.54% ± 3.64 | −3.89% ± 0.51** | −9.85% ± 0.62** |
24 h | 84.88% ± 1.75 | 1.76% ± 0.12** | −5.87% ± 0.62** |